Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bp Consulting, Inc
ClinicalTrials.gov Identifier:
NCT00758199
First received: September 22, 2008
Last updated: March 14, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)